How to Get Crestor (Rosuvastatin) in Washington State

What rosuvastatin is, and what it is not

Rosuvastatin is the generic name for the branded product Crestor, an oral, once-daily statin in the HMG-CoA reductase inhibitor class. It is FDA-approved for lowering LDL cholesterol and reducing cardiovascular risk in eligible adults, and it is available only by prescription. It is not a controlled substance, which is why telehealth prescribing and interstate prescription transfer for it are comparatively simple compared with controlled medications.

Rosuvastatin is a high-intensity statin that any Washington-licensed physician, nurse practitioner, or physician assistant can prescribe after reviewing a lipid panel and liver enzymes, and it can be initiated through a legally compliant telehealth visit as well as an in-person one. Coverage, prior-authorization rules, and cash prices are the parts of this picture that shift over time and by payer, so they need to be confirmed at the point of care rather than treated as fixed facts.

What is established, what is plausible, and what is not settled

Established: Rosuvastatin is FDA-approved for hyperlipidemia and ASCVD risk reduction. It lowers LDL-C in a dose-dependent way, and clinical trial evidence (the JUPITER trial in patients with elevated CRP, and the Cochrane review of statins for primary prevention) supports a meaningful reduction in cardiovascular events for appropriately selected patients. Washington state law permits MDs, DOs, ARNPs, and PA-Cs to prescribe it, and permits telehealth visits for non-controlled medications.

Plausible but not yet standard of care: Emerging observational research has examined whether statin use is associated with lower rates of primary liver cancer in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), independent of age and cirrhosis status (PubMed, 2026). This is observational evidence in a specific population, not a reason to start or continue a statin for liver cancer prevention, and it has not changed any guideline recommendation.

Not established from the material available for this page: Precise, current dollar figures for cash prices, exact Washington Medicaid turnaround times, and an exact county-by-county pharmacy count are the kind of numbers that change on a rolling basis and cannot be stated with confidence here. Treat any specific price or turnaround time you read as a starting estimate to verify, not a guarantee.

Who can prescribe Crestor in Washington

You do not need a cardiologist or lipid specialist. Washington law grants prescriptive authority to several clinician types, and any of them can evaluate your lipid profile and prescribe rosuvastatin if it is appropriate:

• Physicians (MD or DO): full prescriptive authority.
• Advanced Registered Nurse Practitioners (ARNPs): Washington law gives ARNPs independent prescriptive authority for non-controlled medications such as statins. The exact statutory citation should be checked against the current Revised Code of Washington rather than assumed from an older summary.
• Physician Assistants (PA-Cs): Washington modernized PA practice rules in recent years to allow independent prescribing without a physician co-signature. As with the ARNP statute, confirm the current text of the law if this detail matters to your situation.

This means primary care clinics, urgent care, and telehealth platforms are all valid entry points for a rosuvastatin prescription.

Should you use telehealth or an in-person visit?

Washington permits telehealth prescribing for non-controlled medications, and rosuvastatin qualifies. A typical telehealth pathway looks like this:

1. Schedule a video or audio visit with a Washington-licensed provider.
2. Share recent lab results, or get an order for a fasting lipid panel and liver panel (ALT, AST).
3. Discuss cardiovascular risk factors: family history, blood pressure, diabetes status, smoking, and any personal or family history of muscle disease.
4. Receive an e-prescription sent to a Washington pharmacy of your choice.

Telehealth is most useful when in-person access is limited, such as in rural counties with few local prescribers. It is less useful if you have a complicated history (advanced kidney disease, known liver disease, or a prior statin-related muscle problem) where an in-person exam and closer follow-up may be warranted. If you develop unexplained muscle pain, weakness, dark urine, or signs of jaundice after starting a statin, that is a reason to contact your prescriber promptly or seek urgent care rather than wait for a routine follow-up, since these can signal rare but serious muscle or liver injury.

Labs to expect before starting

Two baseline panels are standard before starting rosuvastatin, consistent with FDA labeling and cholesterol management guidelines:

Fasting lipid panel: total cholesterol, LDL-C, HDL-C, and triglycerides. A 9 to 12 hour fast is preferred, though non-fasting values are acceptable for initial screening in current guideline-based practice.

Liver enzymes (ALT and AST): rosuvastatin is hepatically handled, and checking liver enzymes before starting is standard practice. Routine periodic liver enzyme monitoring after starting is generally no longer required for most patients unless there is a clinical reason to check, which is a shift from older statin-era practice.

Some prescribers also check a baseline hemoglobin A1c or fasting glucose, because statin therapy as a class has been associated with a modest increase in new-onset diabetes in trial populations. The magnitude of that increase varies by study and population, and any specific percentage attached to a single trial should be checked against the original publication before being treated as a precise number for an individual patient.

Drug interactions worth asking your prescriber about

Rosuvastatin is a substrate of hepatic uptake transporters (notably OATP1B1), and drugs that inhibit those transporters can raise statin blood levels. Recent laboratory and physiologically based pharmacokinetic modeling research has specifically examined dicloxacillin and flucloxacillin, common penicillin-class antibiotics, as inhibitors of these hepatic uptake transporters (PubMed, 2025). This is in vitro and modeling evidence, not a clinical trial in patients, so the real-world size of any interaction and whether a dose adjustment is warranted has not been established. If you are prescribed one of these antibiotics while taking rosuvastatin, it is reasonable to mention both medications to your prescriber or pharmacist so they can decide whether monitoring or a temporary adjustment makes sense, rather than assuming this page's description substitutes for that conversation.

Insurance coverage and prior authorization

Coverage details below reflect general patterns as of this writing and are the parts of this article most likely to change. Confirm current terms with your plan.

Commercial insurance: generic rosuvastatin is commonly placed on preferred formulary tiers by major Washington commercial plans. Copay amounts vary by plan and pharmacy and should be checked through your insurer's current formulary rather than assumed from a general estimate.

Washington Apple Health (Medicaid): generic rosuvastatin is generally covered. Brand-name Crestor typically requires prior authorization, with documentation such as an adverse reaction to the generic or a documented therapeutic failure. Prior authorization criteria and turnaround windows are set by the Washington Health Care Authority's preferred drug list, which is updated periodically; check the current published list rather than relying on a fixed turnaround time from this article.

Medicare Part D: generic rosuvastatin is commonly placed on a low formulary tier. Medicare Part D has an annual out-of-pocket cap under the Inflation Reduction Act that took effect starting in 2025; confirm the current-year cap amount directly with Medicare.gov or your plan, since program parameters can be updated.

Prior authorization documentation typically includes:

• Diagnosis code supporting the hyperlipidemia or ASCVD indication
• Recent lipid panel results
• Documentation of a generic statin trial or intolerance, for brand-name requests
• The prescriber's clinical rationale

Pharmacy access across Washington

Generic rosuvastatin is stocked at the large majority of retail pharmacies statewide, including national chains, grocery-store pharmacies, and independent pharmacies, with mail-order options available through most insurers for 90-day supplies. Washington also licenses 503A compounding pharmacies that can prepare patient-specific formulations, such as a liquid suspension for someone who cannot swallow tablets, when a prescriber writes a patient-specific order. Cash price ranges for a 30-tablet supply of generic rosuvastatin fluctuate by pharmacy, discount program, and date; a specific dollar figure is not reliable enough to quote here and should be checked at the pharmacy or through a current discount-card lookup.

Transferring an existing prescription to Washington

If you are moving to Washington or staying for an extended period, you can generally transfer an existing rosuvastatin prescription. Call your new Washington pharmacy and provide your current pharmacy's name and phone number; the receiving pharmacist verifies the prescription with the originating pharmacy and transfers the remaining refills. No new prescriber visit is required for the transfer itself, though the pharmacy may flag the prescription if it is close to expiring. Because rosuvastatin is not a controlled substance, an out-of-state prescription from an actively licensed prescriber is generally honored for transfer purposes.

Dosing overview, not individualized dosing advice

The FDA label describes a dose range from 5 mg to 40 mg daily, taken once a day with or without food. Lower starting doses are generally reserved for people at increased risk of muscle-related side effects (for example, certain genetic backgrounds, significant kidney impairment, or use of interacting medications), while higher doses are reserved for patients who need larger LDL reductions and have not reached goals on a lower dose. LDL-lowering effect increases with dose, though the exact percentage reduction at each dose varies across studies and should not be treated as a guarantee for an individual patient. This is general label information, not a recommendation for what dose is right for you; that decision belongs to your prescriber based on your labs, other medications, and risk factors.

Common side effects reported in trials include headache, muscle aches, and nausea. Statins are generally avoided in pregnancy and in people with active, untreated liver disease, and alternatives such as ezetimibe or, for higher-risk patients who cannot tolerate statins, PCSK9 inhibitors exist and can be discussed with your prescriber if rosuvastatin is not a good fit.

Realistic timeline

A typical, non-guaranteed sequence for a Washington resident starting from scratch:

• Day 1: schedule a telehealth or in-person visit; same-day telehealth slots are commonly available.
• Day 1 to 2: labs are ordered and drawn; results often return within one to two days.
• Day 2 to 3: the prescriber reviews labs and sends the prescription to your pharmacy.
• Day 3 to 4: the pharmacy fills the prescription, often within hours of receiving it.

If you already have a recent lipid panel on file, this can compress to one to two days. Prior authorization for brand Crestor under Medicaid, or additional workup for complex medical histories, can add time.

Verification checklist: stable facts versus facts you must confirm yourself

Use this to distinguish rosuvastatin information that remains stable from details requiring current verification before making treatment decisions.

Stable, federal or clinical facts (safe to rely on without re-checking today):

• Rosuvastatin is FDA-approved and prescription-only; it is not a controlled substance.
• It is an HMG-CoA reductase inhibitor taken once daily.
• A fasting lipid panel and liver enzymes are standard before starting.
• Statins as a class are generally avoided in pregnancy and active liver disease.
• Muscle pain/weakness with dark urine, or signs of jaundice, warrant prompt medical contact.

Washington scope-of-practice facts (stable in direction, verify exact statute text if it matters to you):

• MDs, DOs, ARNPs, and PA-Cs can all prescribe rosuvastatin in Washington.
• Telehealth is a legal channel for prescribing non-controlled medications like this one.

Date-sensitive facts you should confirm before relying on them:

• Whether your specific commercial plan places generic rosuvastatin on a $0 copay tier.
• Whether Washington Apple Health's preferred drug list still requires prior authorization for brand Crestor, and what documentation it currently asks for.
• The current Medicare Part D annual out-of-pocket cap amount.
• Cash price at your specific pharmacy today, with or without a discount card.
• Standard versus urgent prior-authorization turnaround times, which are set by payer policy and can change.

If a fact falls in the third category, treat any number you find (including in this article) as a starting point to confirm with your pharmacy, insurer, or the Washington Health Care Authority, not as a final answer.

Common questions